| Item title |
Created |
|
Reducing the Health and Economic Burden of Chronic Diseases in Ontario: The Role of Biopharmaceuticals
|
Friday, 18 May 2012 |
|
LSO Board Member, David Allan Lauded for Leadership – Biotechnology Leader Named to Industry Award
|
Tuesday, 15 May 2012 |
|
BIO 2012 Canadian Coaching Initiative
|
Thursday, 10 May 2012 |
|
The Medtech Challenge
|
Thursday, 10 May 2012 |
|
MaRS Innovation paves the way for innovative drug development partnership in China
|
Monday, 07 May 2012 |
|
Sanofi BioGENEius Challenge Canada Greater Toronto Area results
|
Wednesday, 25 April 2012 |
|
EMD Millipore and the Centre for Commercialization of Regenerative Medicine Collaborate
|
Tuesday, 24 April 2012 |
|
New Industry Partnership to Strengthen Regenerative Medicine Industry in Canada
|
Tuesday, 24 April 2012 |
|
Razzle dazzle ’em: The road to BIO 2012
|
Tuesday, 24 April 2012 |
|
Cynapsus Therapeutics Inc., A Global Opportunity with a Large Untapped Parkinson's Market
|
Tuesday, 24 April 2012 |
|
Life Sciences Ontario Elects Paul Lucas as New President & Chair
|
Monday, 23 April 2012 |
|
LSO Annual Report 2012
|
Monday, 23 April 2012 |
|
BIO2012 – Ontario Industry Engagement webinar
|
Thursday, 19 April 2012 |
|
Porter Airlines assurera le premier vol commercial avec un avion propulsé au biocarburant au Canada
|
Tuesday, 27 March 2012 |
|
Porter Airlines to Conduct Canada’s First Biofuel-Powered Revenue Flight
|
Monday, 26 March 2012 |
Page 1 of 14
